Concepedia

Siyu Li

SL

Statistics

Publications

14

Citations

980

H-Index

11

Active since

2016

Affiliations

Beijing University of Chinese Medicine(Current)

Regeneron (United States)

Chinese Academy of Medical Sciences & Peking Union Medical College

Memorial Sloan Kettering Cancer Center

China Academy of Chinese Medical Sciences

Siyu Li is an author at Beijing University of Chinese Medicine specializing in radiation oncology, oncology, and cancer therapeutics.

ORCID

Top concepts

Publications per year

2016–2024

14

Publications

14

Activity and safety of ceritinib in patients with ALK-rearranged non-small-cell lung cancer (ASCEND-1): updated results from the multicentre, open-label, phase 1 trial

Dong‐Wan Kim, Ranee Mehra, Daniel S.W. Tan et al. · The Lancet Oncology · 2016 · 467 citations · Full text

, , +5

Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: a single-arm, open-label, phase 2 trial

Thomas U. Marron, Maria Isabel Fiel, Pauline Hamon et al. · ˜The œLancet. Gastroenterology & hepatology · 2022 · 207 citations · Full text

, , +10

Cemiplimab Plus Chemotherapy Versus Chemotherapy Alone in Advanced NSCLC: 2-Year Follow-Up From the Phase 3 EMPOWER-Lung 3 Part 2 Trial

Tamta Makharadze, Miranda Gogishvili, Tamar Melkadze et al. · Journal of Thoracic Oncology · 2023 · 85 citations · Full text

Novel anti-obesity effect of scutellarein and potential underlying mechanism of actions

Yiguang Lin, Nina Ren, Siyu Li et al. · Biomedicine & Pharmacotherapy · 2019 · 44 citations · Full text

Role of A2B adenosine receptor-dependent adenosine signaling in multi-walled carbon nanotube-triggered lung fibrosis in mice

Biying Liu, Qizheng Bing, Siyu Li et al. · Journal of Nanobiotechnology · 2019 · 34 citations · Full text

1–5 of 14